This is the protocol for a review and there is no abstract. The objectives are as follows:
1. To determine the event-free survival (EFS) and overall survival (OS) in children with medulloblastoma receiving chemotherapy as a part of their treatment, as compared to children not receiving chemotherapy as part of their treatment.
2. To determine the EFS and OS in children with medulloblastoma receiving standard dose radiotherapy without chemotherapy, as compared to children receiving reduced dose radiotherapy with chemotherapy.
1. To determine possible adverse effects of chemotherapy and radiotherapy, including long-term side effects.
2. To determine possible effects of treatment on the quality of life.
If you can't find a tool you're looking for, please click the link at the top of the page to "Go to old article view". Alternatively, view our Knowledge Base articles for additional help. Your feedback is important to us, so please let us know if you have comments or ideas for improvement.